Purpose: The purpose of this study was to assess patient participation in advance care planning (ACP) and the decision to enroll in hospice. Methods: One hundred sixty-five family members of patients who died in hospice between January 2004 and September 2004 returned an anonymous survey (165=380; 43% response rate). Results: Forty-nine percent of family members reported that the patient was not involved in the hospice enrollment decision. The majority of respondents (78%) reported one or more people helped make the decision to enroll in hospice. For patients reported as being involved in the decision to enroll in hospice (either independently or in a shared capacity) they were more likely to have cancer (odds ratio
Introduction
T he philosophies of palliative care and hospice emphasize the importance of providing care that is consistent with the preferences of the patient. 1 In the United States, approximately one third of all people who died in 2008 were cared for by hospice at their time of death (approximately 963,000). 2 The decision to enroll in hospice is challenging and complex. Research on how involved patients and their families are in the decision to enroll in hospice is limited. Results from one study indicated that 57% of family members made the decision for their relative to enroll in hospice because the patient was cognitively impaired. 3 Results from a study of patients with advanced cancer (with no cognitive impairment) who enrolled in hospice, reported that 42% of patients let their families make the decision about hospice enrollment. 4 These findings support the finding that patients so close to death may be either cognitively unable or emotionally unwilling to participate in decisions regarding their medical treatment. In light of the research in which 40%-60% of patients are not participating in the decision to enroll in hospice, knowledge of patients' preferences becomes critical.
Research on advance care planning in the community and nursing home settings has highlighted racial disparities in the completion of an advance directive. [5] [6] [7] [8] Findings from a national survey of bereaved family members found that approximately 70% of hospice patients had at least one advance directive, however, the vast majority of those patients were white. 9 What is not known is whether patients who enroll in hospice discuss their health care preferences with their family caregiver before enrolling in hospice. The goals of this study were to: (1) measure the extent to which patients are involved in the decision to enroll in hospice; (2) assess patient and caregiver characteristics associated with patient involvement in the decision to enroll in hospice; (3) determine if discussions about life-sustaining treatments are occurring between the patient and family caregiver prior to hospice enrollment; and (4) describe the types of advance directive documentation patients have completed prior to enrolling in hospice.
Methods

Design
An anonymous survey study design was used to collect data from the family caregiver of a patient who died while enrolled in hospice care.
Sample
Family caregivers of hospice patients who died between January 1, 2004 and September 30, 2004 from a hospice operated by a large, university-affiliated health system were eligible to be included in this study. One survey was sent per patient to the self-identified primary caregiver of that patient (N ¼ 380).
Survey
Each mailing contained a cover letter indicating the survey was anonymous, a copy of the survey, and a self-addressed stamped envelope to return the survey. The survey was organized into three parts: family caregiver and patient demographics and characteristics, decision making to enroll in hospice, and advance care planning.
Demographics and characteristics. The survey was organized first with demographic questions about the family caregiver and the hospice patient (family caregiver: gender, race, age [in years], and relationship to hospice patient; hospice patient: age [year born, converted into age using July 1 for the birthday]), and primary diagnosis. Next, questions about location of death (e.g., home, hospital, nursing home, in patient hospice) and length of stay in hospice (e.g., 1-3 days, 4-7 days, >7 days up to 1 month, >1 month up to 2 months; >2 months up to 6 months; >6 months) were collected. For length of stay in hospice the smallest categories, ''1-3 days'' and ''4-7 days'' were collapsed into '' 7 days'' for analyses.
Patient involvement in the decision to enroll hospice. The degree of the patients' participation in making the decision to enroll hospice was measured by asking caregivers the following question: ''Please choose the statement that best describes how you and the patient made the decision to enroll in hospice. Would you say that'':
1. The patient made the decision entirely on his=her own. 2. The patient made the decision but got advice from others. 3. The patient shared the decision with others. 4. The patient let others make the decision but had an opinion. 5. The patient was not involved in the decision.
This question was adapted from Degner and colleagues' 10 question about medical decision making 11, 12 and has been used with caregivers of hospice patients. 13 Involvement in the decision to enroll in hospice was measured by asking, ''Did other people help you and=or the patient to make the decision to enroll in hospice?'' An extensive list of options (e.g., physician, nurse, social worker, spouse, daughter, son, parent, niece=nephew, grandchild) as well as an open-ended write-in option were provided for the family caregiver to select as many choices as they wanted.
Advance care planning. Questions about advance care planning (ACP) focused on specific life-sustaining treatments (e.g., cardiopulmonary resuscitation [CPR], mechanical ventilation, feeding tube, dialysis, intravenous fluids, and antibiotics). For each treatment family caregivers were asked to recall if they discussed the treatment with the patient prior to enrollment in hospice (response options: yes, no, or unsure). Questions about the completion of a written advance directive (specifically, a living will) prior to the patient enrolling in hospice and any revisions to this document after hospice enrollment were also asked. Finally, questions pertaining to having a durable power of attorney for health care, and how helpful the document was (or would have been), were asked.
Analyses
Frequencies and basic summary statistics are presented. Parametric and nonparametric tests were used to make group comparisons (e.g., w 2 , Wilcoxon rank sum test). Finally, univariate logistic regression is used to describe the relationship between caregiver characteristics and types of advance care planning treatment discussions family caregivers had with their relative who enrolled in hospice. Involvement in the decision to enter hospice was collapsed into three groups: (1) the patient made the decision to enroll in hospice, (2) the patient shared the decision with others, and (3) the patient was not involved in the decision to enroll in hospice. 12 
Results
One hundred sixty-five surveys were returned by family caregivers (response rate ¼ 43.4%). Family caregivers were on average 61.1 years old (median: 61 years), female (71.5%), and white (83.5%; Table 1 ). The majority of patients were over the age of 70 (median: 76 years; mean: 73.4 years) and had a primary diagnosis of cancer (70.3%). Just over one third of the patients (35.8%) had a length of stay (LOS) of less than or equal to 7 days. An additional 40.8% of patients had a LOS greater than 7 days but less than 2 months (60 days). Patients with a noncancer primary diagnosis were older (median: 84 years) than patients with a primary diagnosis of cancer (median: 71 years; rank sum, p < 0.001) and were more likely to be cared for by an adult child or child-in-law (22=49; 45%) than were patients with a primary diagnosis of cancer (34=116; 29%) [(
How involved are patients in the decision to enter hospice?
Forty-nine percent (81=165) of family caregivers reported that their relative was not involved in the final decision to enroll in hospice, 15.8% (26=165) reported that the patient 520 HIRSCHMAN ET AL.
shared the decision making with others, and 30.3% (50=165) reported that the patient made the final decision. Eight surveys (4.9%) had missing data for this question ( Who helps make the decision to enter hospice?
The majority of family caregivers (78.7%; 122=157) reported that at least one person helped in the decision making process to enroll the patient in hospice (mean ¼ 2; range, 1-7; Table 3 ). Just under one quarter of the sample (n ¼ 22%) reported that the patient made the decision to enroll in hospice and did not involve anyone else (35=157). Physicians (58.0%; 91=157), were the most commonly reported health care professionals who were involved in the decision to enroll the patient in hospice, followed by social workers (25.5%; 40=157), and nurses (20.4%; 32=157). The spouse (51.6%; 81=157) and adult child=children, daughter-or son-in-law (38.9%; 61=157) of the patient were also involved in the hospice enrollment decision.
What are patients and their family caregivers talking about before enrolling in hospice?
The three most common advance care planning topics discussed prior to the patient enrolling in hospice were the use of mechanical ventilation (72.0%; 113=157), CPR (68.4%; 106=155), and feeding tubes (64.7%; 101=156; Table 3 ). Interestingly, mechanical ventilation, CPR, and feeding tube discussions were associated with the race of the caregiver. White family caregivers were more likely to have had a conversation with the patient about feeding tubes (OR ¼ 4.7; p ¼ 0.001), CPR (OR ¼ 3.9; p ¼ 0.002), or mechanical ventilation (OR ¼ 2.7; p ¼ 0.02) than black=African American or multiracial family caregivers. No other patient or family caregiver characteristics were significantly associated with advance care planning discussion topics.
Are patient's completing advance directives before enrolling in hospice?
Family caregivers reported that most patients had a either a living will or a durable power of attorney for health care prior to enrolling in hospice (69.1% and 61.8%, respectively). Fiftysix percent of patients had both a living will and a durable power of attorney for health care (DPOAHC; 93=165). Four family caregivers reported that a living will was completed after the patient enrolled in hospice, and seven caregivers reported the patient revised their living will after enrolling in hospice. Among family caregivers who reported not having a DPOAHC, 17.5% (11=63) responded that it would have been helpful to have this document when enrolling the patient in hospice. White caregivers were more likely to report that their relative had a living will or DPOAHC (OR ¼ 4.2, p ¼ 0.001) than black=African American or multi-racial caregivers. Patients who had a written advance directive prior to hospice enrollment were more likely to have discussed treatment preferences such as mechanical ventilation (OR ¼ 7.8, p < 0.001), CPR (OR ¼ 5.4, p < 0.001), feeding tubes (OR ¼ 6.1, p < 0.001), inravenous fluids (OR ¼ 3.6, p ¼ 0.001), dialysis (OR ¼ 3.4, p ¼ 0.006), and antibiotics (OR ¼ 2.6, p ¼ 0.01). Results remained significant after controlling for race.
Discussion
This study highlights that patients are involved in the decision to enroll in hospice, are having advance care planning discussions, and do complete written advance directives. Similar to other research findings, racial differences exist in the completion of written advance directives and advance care planning discussions. These data shed light on three important insights into the decision to enroll in hospice and advance care planning.
First, although the majority of patients are involved in the decision to enroll in hospice, 49.1% of patients are not involved or involved peripherally in the decision to enroll in hospice. Not surprisingly, cognitive impairment (e.g., dementia) was highly associated with not being involved in the decision to enroll in hospice. Yet overall, hospice enrollees in our study allowed family and physicians to guide their decisions. Furthermore, a larger group of family members reported that a variety of health care professionals and family are involved, both with and on behalf of the patient, in the decision to enroll in hospice. This has implications on how and to whom information about hospice is marketed. There may be an opportunity to use guided questions to help both patients and family caregivers to identify other people they want involved in the decision to enroll in hospice.
Second, being black=African American or multiracial in this study was associated with little or no advance care planning. White patients were more likely to have had discussions with their family caregiver about life-prolonging treatments such as CPR, mechanical ventilation, and feeding tubes in comparison to black=African American hospice patients. It is not clear why this type of informal advance care planning discussion is different between the two groups but other researchers theorize this may be due to cultural factors. 7, 14 Further research is needed to both understand the barriers to advance care planning for this group and test interventions to improve advance care planning.
Third, overall the majority family caregivers report having ACP discussions with their relative regarding end-of-life treatments and putting advance directives together. These results are similar to other researchers' findings that among hospice patients that had specific end-of-life care wishes 72.4% had advance directives as compared to 32.1% with no advance directive. 9 Although many living wills do have a laundry list of treatment options that go into effect once a patient is deemed terminally ill, 28%-59% of patients in our study came into hospice without having specific treatment discussions with their family caregivers. The differences between having an advance directive and discussing end-of-life care preferences listed in the advance directive are important since without preference discussions many family caregivers find themselves without the knowledge, judgment, or courage to perform their responsibility as a proxy decision maker. [15] [16] [17] There are a number of study limitations. First, family members were asked for their recollection of advance care planning and the decision to enroll in hospice. It is possible that the families' recollections were different from what the patients' perspectives on advance care planning and the decision to enroll in hospice might have been. A second limitation of the study is the sample distribution of cancer vs. non-cancer patients. There were more cancer diagnoses (70.3%) in our study than compared to the national statistics (46.4%) at the time of this study. 18 However, the high percentage of patients dying with cancer as a primary diagnosis was reflective of the hospice at that time (71%). Although our response rate was only 43.4% it was higher than the hospice's satisfaction survey response rate at the time (approximately 25%). In addition, patient characteristics (i.e., age, gender, and cancer diagnosis) in this sample were similar to the overall patient characteristics of patients cared for by this hospice during this time frame. Finally, questions about spirituality= religiosity and psychosocial characteristics of the family caregiver may have been useful to know in relation to advance care planning discussions. However, these questions were not asked due to space limitation and respondent burden of a larger survey.
These data provide insight into advance care planning and the decision to enroll in hospice. Further research is needed to better understand racial differences and advance care planning and what factors contribute to this disparity. Educating patients and family caregivers on how to discuss health care preferences before the end of life is key. This will help proxy decision makers, most often family caregivers, make end-oflife decisions based on what the patient have would wanted. 
